Evrópusambandið - ítalska - EMA (European Medicines Agency)

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - agenti antineoplastici - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - dulaglutidum - soluzione per iniezione penna pre-riempita monouso - dulaglutidum 3.0 mg, natrii citras dihydricus corresp. natrium 0.32 mg, acidum citricum, mannitolum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - antidiabétique, prévention d'événements cardiovasculaires - biotechnologika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - dulaglutidum - soluzione per iniezione penna pre-riempita monouso - dulaglutidum 4.5 mg, natrii citras dihydricus corresp. natrium 0.32 mg, acidum citricum, mannitolum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - antidiabétique, prévention d'événements cardiovasculaires - biotechnologika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - tirzepatidum - soluzione iniettabile in penna pre-riempita - tirzepatidum 2.5 mg, dinatrii phosphas heptahydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 0.5 ml corresp., natrium 1.8 - 1.9 mg. - diabète sucré de type 2 - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - tirzepatidum - soluzione iniettabile in penna pre-riempita - tirzepatidum 5 mg, dinatrii phosphas heptahydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 0.5 ml corresp., natrium 1.8 - 1.9 mg. - diabète sucré de type 2 - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - tirzepatidum - soluzione iniettabile in penna pre-riempita - tirzepatidum 7.5 mg, dinatrii phosphas heptahydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 0.5 ml corresp., natrium 1.8 - 1.9 mg. - diabète sucré de type 2 - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - tirzepatidum - soluzione iniettabile in penna pre-riempita - tirzepatidum 10 mg, dinatrii phosphas heptahydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 0.5 ml corresp., natrium 1.8 - 1.9 mg. - diabète sucré de type 2 - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - tirzepatidum - soluzione iniettabile in penna pre-riempita - tirzepatidum 12.5 mg, dinatrii phosphas heptahydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 0.5 ml corresp., natrium 1.8 - 1.9 mg. - diabète sucré de type 2 - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

eli lilly (suisse) sa - tirzepatidum - soluzione iniettabile in penna pre-riempita - tirzepatidum 15 mg, dinatrii phosphas heptahydricus, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 0.5 ml corresp., natrium 1.8 - 1.9 mg. - diabète sucré de type 2 - synthetika

Ítalía - ítalska - AIFA (Agenzia Italiana del Farmaco)

viatris healthcare limited - pimecrolimus - pimecrolimus